Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, December 18, 2023
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
Steven Seedhouse Initiated (VERA) at Buy and Held Target at $29 on, Dec 18th, 2023
Steven Seedhouse of Raymond James, Initiated "Vera Therapeutics, Inc." (VERA) at Buy and Held Target at $29 on, Dec 18th, 2023.
Steven has made no other calls on VERA in the last 4 months.
There are 3 other peers that have a rating on VERA. Out of the 3 peers that are also analyzing VERA, 0 agree with Steven's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Steven
- Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $22 on, Thursday, November 30th, 2023
- Farzin Haque of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $26 on, Friday, November 10th, 2023
- Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $25 on, Tuesday, September 26th, 2023
